As previously mentioned, the immunophenotype of ALK+ ALCL is determined by the detection of ALK protein expression using a monoclonal antibody developed by Pulford in 1997 [4] that is immunohistochemically highly sensitive and specific. Here, ALK is linked to anaplastic large cell lymphoma.